Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Galantamine MeSH Descriptor Data 2025


MeSH Heading
Galantamine
Tree Number(s)
D03.132.052.500
D03.633.100.079.525
Unique ID
D005702
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D005702
Scope Note
A benzazepine derived from norbelladine. It is found in GALANTHUS and other AMARYLLIDACEAE. It is a cholinesterase inhibitor that has been used to reverse the muscular effects of GALLAMINE TRIETHIODIDE and TUBOCURARINE and has been studied as a treatment for ALZHEIMER DISEASE and other central nervous system disorders.
Entry Term(s)
Galantamin
Galanthamine
Galanthamine Hydrobromide
Lycoremine
Nivalin
Nivaline
Razadyne
Reminyl
Pharm Action
Cholinesterase Inhibitors
Parasympathomimetics
Nootropic Agents
Registry Numbers
0D3Q044KCA
0
1953-04-4
MJ4PTD2VVW
Related Numbers
1953-04-4
357-70-0
MJ4PTD2VVW
CAS Type 1 Name
6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-
NLM Classification #
QV 124
Public MeSH Note
2004; see GALANTHAMINE 1999-2003;RAZADYNE was indexed under GALANTAMINE 2006-2009
History Note
2004(1999)
Date Established
2004/01/01
Date of Entry
1999/01/01
Revision Date
2017/05/24
Galantamine Preferred
Nivaline Narrower
Galanthamine Hydrobromide Narrower
Razadyne Narrower
page delivered in 0.147s